oral glp-1 agonist brand name Market Overview: Agonists and the Obesity Market | Blog GLP-1 Receptor Agonists List: Complete

Ultimately, I believe there are certain populations where GLP-1 agonists may be appropriate, beneficial, and promote impactful changes to health

These findings are consistent with data accessed on April 24, 2025

Further weight gain is predicted by 2030 (205, 206)

23 In clinical trials, treatment-discontinuation rates are around 5% to 10%

[DOI] [PMC free article] [PubMed] [Google Scholar] 118.Miller R.A., Chu Q., Xie J., Foretz M., Viollet B., Birnbaum M.J

Around 10% of people carry genetic variations linked to GLP-1 resistance. These individuals appear to have higher-than-normal levels of the hormone glucagon-like peptide-1 (GLP-1)